HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression.

Abstract
The normal epithelial cell-specific-1 (NES1)/kallikrein 10 gene is expressed in normal mammary epithelial cells, but its expression is dramatically decreased in breast cancer cell lines. Now, we have cloned and characterized the active promoter region of NES1. Using a luciferase reporter system, we demonstrate that most tumor cell lines are able to support full or partial transcription from the NES1 promoter, suggesting a role for promoter-independent cis-acting mechanisms of loss of NES1 expression. We show that hypermethylation of the NES1 gene represents one such mechanism. Using methylation-specific PCR and sequence analysis of sodium bisulfite-treated genomic DNA, we demonstrate a strong correlation between exon 3 hypermethylation and loss of NES1 mRNA expression in a panel of breast cancer cell lines and in primary tumors. Treatment of NES1-nonexpressing cells with a demethylating agent led to reexpression of NES1, suggesting an important role of hypermethylation in the loss of NES1 expression. We suggest that hypermethylation is responsible for tumor-specific loss of NES1 gene expression. Our results also suggest that hypermethylation of the NES1 gene may serve as a potential marker for breast cancer.
AuthorsB Li, J Goyal, S Dhar, G Dimri, E Evron, S Sukumar, D E Wazer, V Band
JournalCancer research (Cancer Res) Vol. 61 Issue 21 Pg. 8014-21 (Nov 01 2001) ISSN: 0008-5472 [Print] United States
PMID11691827 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antimetabolites, Antineoplastic
  • Biomarkers, Tumor
  • RNA, Messenger
  • Decitabine
  • Luciferases
  • KLK10 protein, human
  • Kallikreins
  • Azacitidine
Topics
  • Antimetabolites, Antineoplastic (pharmacology)
  • Azacitidine (analogs & derivatives, pharmacology)
  • Biomarkers, Tumor (biosynthesis, genetics)
  • Breast Neoplasms (genetics, metabolism)
  • CpG Islands
  • DNA Methylation (drug effects)
  • Decitabine
  • Exons
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Introns
  • Kallikreins (biosynthesis, genetics)
  • Luciferases (genetics, metabolism)
  • Promoter Regions, Genetic
  • RNA, Messenger (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: